Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies.

CONCLUSIONS: Our results suggest that targeted therapies are safe in  patients with SAPH. Controlled trials are warranted before therapeutic recommendations can be made. PMID: 25078636 [PubMed - in process]
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - Category: Respiratory Medicine Tags: Sarcoidosis Vasc Diffuse Lung Dis Source Type: research